278 related articles for article (PubMed ID: 36869400)
41. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
42. Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin-EGFR crosstalk.
Li D; Lo W; Rudloff U
Clin Transl Med; 2018 Feb; 7(1):7. PubMed ID: 29468433
[TBL] [Abstract][Full Text] [Related]
43. E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man.
Humar B; Blair V; Charlton A; More H; Martin I; Guilford P
Cancer Res; 2009 Mar; 69(5):2050-6. PubMed ID: 19223545
[TBL] [Abstract][Full Text] [Related]
44. Panel testing reveals nonsense and missense CDH1 mutations in families without hereditary diffuse gastric cancer.
Huynh JM; Laukaitis CM
Mol Genet Genomic Med; 2016 Mar; 4(2):232-6. PubMed ID: 27064202
[TBL] [Abstract][Full Text] [Related]
45. Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report.
Black MD; Kaneshiro R; Lai JI; Shimizu DM
Hawaii J Med Public Health; 2014 Jul; 73(7):204-7. PubMed ID: 25089230
[TBL] [Abstract][Full Text] [Related]
46. A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain.
Rodriguez-Sanjuan JC; Fontalba A; Mayorga M; Bordin MC; Hyland SJ; Trugeda S; Garcia RA; Gomez-Fleitas M; Fernandez F; Caldas C; Fernandez-Luna JL
Eur J Surg Oncol; 2006 Dec; 32(10):1110-3. PubMed ID: 16870389
[TBL] [Abstract][Full Text] [Related]
47.
Ben Aissa-Haj J; Kabbage M; Othmen H; Saulnier P; Kettiti HT; Jaballah-Gabteni A; Ferah A; Medhioub M; Khsiba A; Mahmoudi M; Maaloul A; Ben Nasr S; Chelbi E; Abdelhak S; Boubaker MS; Azzouz MM; Rouleau E
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327954
[TBL] [Abstract][Full Text] [Related]
48. Germline CDH1 variants in hereditary diffuse gastric cancer syndrome with focus on younger women.
Corso G; Comelli G; Veronesi P; Bianchi B; Petitto S; Polizzi A; Girardi A; Cioffi A; La Vecchia C; Bagnardi V; Magnoni F
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16147-16155. PubMed ID: 37639007
[TBL] [Abstract][Full Text] [Related]
49. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.
Oliveira C; Pinheiro H; Figueiredo J; Seruca R; Carneiro F
Prog Mol Biol Transl Sci; 2013; 116():337-59. PubMed ID: 23481202
[TBL] [Abstract][Full Text] [Related]
50. Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management.
Rocha JP; Gullo I; Wen X; Devezas V; Baptista M; Oliveira C; Carneiro F
Histopathology; 2018 Dec; 73(6):878-886. PubMed ID: 30014492
[TBL] [Abstract][Full Text] [Related]
51. Hereditary diffuse gastric cancer (HDGC). An overview.
Taja-Chayeb L; Vidal-Millán S; Trejo-Becerril C; Pérez-Cárdenas E; Chávez-Blanco A; Domínguez-Gómez G; González-Fierro A; Romo-Pérez A; Dueñas-González A
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101820. PubMed ID: 34656755
[TBL] [Abstract][Full Text] [Related]
52. CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland.
Jakubowska A; Lawniczak M; Wojnarska B; Cybulski C; Huzarski T; Byrski T; Tołoczko-Grabarek A; Jaworska K; Durda K; Starzyńska T; Lubiński J
Fam Cancer; 2010 Dec; 9(4):605-8. PubMed ID: 20842455
[TBL] [Abstract][Full Text] [Related]
53. Prophylactic laparoscopic-assisted total gastrectomy for hereditary diffuse gastric cancer.
Francis WP; Rodrigues DM; Perez NE; Lonardo F; Weaver D; Webber JD
JSLS; 2007; 11(1):142-7. PubMed ID: 17651578
[TBL] [Abstract][Full Text] [Related]
54. Clinical features and cancer risk in families with pathogenic
Xicola RM; Li S; Rodriguez N; Reinecke P; Karam R; Speare V; Black MH; LaDuca H; Llor X
J Med Genet; 2019 Dec; 56(12):838-843. PubMed ID: 31296550
[TBL] [Abstract][Full Text] [Related]
55. Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy.
Lynch HT; Kaurah P; Wirtzfeld D; Rubinstein WS; Weissman S; Lynch JF; Grady W; Wiyrick S; Senz J; Huntsman DG
Cancer; 2008 Jun; 112(12):2655-63. PubMed ID: 18442100
[TBL] [Abstract][Full Text] [Related]
56. [18F]Fluoro-2-deoxy-D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier.
van Kouwen MC; Drenth JP; Oyen WJ; de Bruin JH; Ligtenberg MJ; Bonenkamp JJ; van Krieken JH; Nagengast FM
Clin Cancer Res; 2004 Oct; 10(19):6456-9. PubMed ID: 15475432
[TBL] [Abstract][Full Text] [Related]
57. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
[TBL] [Abstract][Full Text] [Related]
58. Prophylactic total gastrectomy for hereditary diffuse gastric cancer. Review of the literature.
Mastoraki A; Danias N; Arkadopoulos N; Sakorafas G; Vasiliou P; Smyrniotis V
Surg Oncol; 2011 Dec; 20(4):e223-6. PubMed ID: 21872467
[TBL] [Abstract][Full Text] [Related]
59. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer.
Corso G; Pedrazzani C; Pinheiro H; Fernandes E; Marrelli D; Rinnovati A; Pascale V; Seruca R; Oliveira C; Roviello F
Eur J Cancer; 2011 Mar; 47(4):631-9. PubMed ID: 21106365
[TBL] [Abstract][Full Text] [Related]
60. Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour.
Oliveira C; de Bruin J; Nabais S; Ligtenberg M; Moutinho C; Nagengast FM; Seruca R; van Krieken H; Carneiro F
Oncogene; 2004 Mar; 23(12):2236-40. PubMed ID: 14661064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
